Blog

Discover the latest updates from Nome Therapeutics — exploring rare disease research, scientific breakthroughs, and innovations in personalized therapies.

20 Rare Disease Family Foundation Statistics Every Patient Advocate Should Know in 2025

Nome Team 11/5/25 Nome Team 11/5/25

20 Rare Disease Family Foundation Statistics Every Patient Advocate Should Know in 2025

Read More

20 Custom Therapy Eligibility Statistics: Critical Data for Rare Disease Patients and Providers in 2025

Nome Team 11/5/25 Nome Team 11/5/25

20 Custom Therapy Eligibility Statistics: Critical Data for Rare Disease Patients and Providers in 2025

Read More

20 Antisense Oligonucleotides (ASO) Development Cost Statistics

Nome Team 11/5/25 Nome Team 11/5/25

20 Antisense Oligonucleotides (ASO) Development Cost Statistics

Read More

22 Pre-Clinical Research Timeline Statistics Every Drug Development Leader Should Know in 2025

Nome Team 11/5/25 Nome Team 11/5/25

22 Pre-Clinical Research Timeline Statistics Every Drug Development Leader Should Know in 2025

Read More

21 Orphan Drug Designation Statistics: The Complete Data Guide for Rare Disease Stakeholders in 2025

Nome Team 11/5/25 Nome Team 11/5/25

21 Orphan Drug Designation Statistics: The Complete Data Guide for Rare Disease Stakeholders in 2025

Read More

20 Rare Genetic Diagnosis Statistics Every Family and Provider Should Know in 2025

Nome Team 11/5/25 Nome Team 11/5/25

20 Rare Genetic Diagnosis Statistics Every Family and Provider Should Know in 2025

Read More

20 Gene Therapy for Rare Diseases Statistics: Essential Data for Patients, Providers, and Researchers in 2025

Nome Team 11/5/25 Nome Team 11/5/25

20 Gene Therapy for Rare Diseases Statistics: Essential Data for Patients, Providers, and Researchers in 2025

Read More

20 AI in Rare Disease Drug Development Statistics Every Stakeholder Should Know in 2025

Nome Team 11/5/25 Nome Team 11/5/25

20 AI in Rare Disease Drug Development Statistics Every Stakeholder Should Know in 2025

Read More

21 Rare Disease Patient-Led Initiative Statistics Every Healthcare Leader Should Know in 2025

Nome Team 11/5/25 Nome Team 11/5/25

21 Rare Disease Patient-Led Initiative Statistics Every Healthcare Leader Should Know in 2025

Read More

N-of-1 Therapy Development Statistics: 22 Key Facts Every Rare Disease Stakeholder Should Know in 2025

Nome Team 11/5/25 Nome Team 11/5/25

N-of-1 Therapy Development Statistics: 22 Key Facts Every Rare Disease Stakeholder Should Know in 2025

Read More

17 Personalized Therapeutics Statistics That Prove Why Rare Disease Patients Need AI-Powered Treatment Platforms

Nome Team 11/5/25 Nome Team 11/5/25

17 Personalized Therapeutics Statistics That Prove Why Rare Disease Patients Need AI-Powered Treatment Platforms

Read More

19 Custom ASO Therapy Statistics: Essential Data on Personalized Rare Disease Treatment in 2025

Nome Team 11/5/25 Nome Team 11/5/25

19 Custom ASO Therapy Statistics: Essential Data on Personalized Rare Disease Treatment in 2025

Read More

21 Ultra-Rare Condition Prevalence Statistics: Essential Data for Patients and Healthcare Providers in 2025

Nome Team 11/5/25 Nome Team 11/5/25

21 Ultra-Rare Condition Prevalence Statistics: Essential Data for Patients and Healthcare Providers in 2025

Read More

15 Essential Resources for Rare Disease Patients in Pennsylvania

Nome Team 10/29/25 Nome Team 10/29/25

15 Essential Resources for Rare Disease Patients in Pennsylvania

Read More

List of Resources For Rare Disease Patients In New York

Nome Team 10/29/25 Nome Team 10/29/25

List of Resources For Rare Disease Patients In New York

Read More

List of Resources For Rare Disease Patients In Florida

Nome Team 10/29/25 Nome Team 10/29/25

List of Resources For Rare Disease Patients In Florida

Read More

ASPA Gene Disorders: Research Update and Personalized ASO Therapy Options

Nome Team 10/29/25 Nome Team 10/29/25

ASPA Gene Disorders: Research Update and Personalized ASO Therapy Options

Read More

ARSA Gene Disorders: Research Update and Personalized ASO Therapy Options

Nome Team 10/29/25 Nome Team 10/29/25

ARSA Gene Disorders: Research Update and Personalized ASO Therapy Options

Read More

GALC Gene Disorders: Research Update and Personalized ASO Therapy Options

Nome Team 10/29/25 Nome Team 10/29/25

GALC Gene Disorders: Research Update and Personalized ASO Therapy Options

Read More

HEXA Gene Disorders: Research Update and Personalized ASO Therapy Options

Nome Team 10/29/25 Nome Team 10/29/25

HEXA Gene Disorders: Research Update and Personalized ASO Therapy Options

Read More